Loading cancer entity…
Loading cancer entity…
Clinical trials
805 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04107480 | PRolaCT - Three Prolactinoma RCTs | unknown | Phase 4 | 880 | Leiden University Medical CenterOTHER | 1 | Jul 20, 2020 | clinicaltrials |
| NCT03083210 | Study of Lanreotide in Metastatic or Recurrent Grade I-II Hindgut NET | unknown | Phase 4 | 28 | Samsung Medical CenterOTHER | 1 | May 20, 2019 | clinicaltrials |
| NCT02759718 |
| Clinical Effectiveness of Serum Chromogranin A Levels on Diagnostic of Pancreatic Neuroendocrine Tumors(CgA) |
| unknown |
| Phase 4 |
| 111 |
| Asan Medical CenterOTHER |
| 0 |
| May 3, 2016 |
| clinicaltrials |
Data updated 22 days agoSource updated Jul 20, 2020source: clinicaltrials